Resveratrol
Information
- Drug Name
- Resveratrol
- Description
- Entry(CIViC)
CIViC
[No Data.]
Annotation
| Description | Associated Genes | Associated Variants | Sensitivity | Supported | Source | Links |
|---|---|---|---|---|---|---|
| Resveratrol inhibits melanoma vasculogenic mimicry... | ROS1 | ROS1 EXPRESSION | Sensitivity | true | MMMP | detail |
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03597568 | Active, not recruiting | N/A | Resveratrol and Vascular Function in CKD | January 1, 2019 | December 31, 2023 |
| NCT06131918 | Active, not recruiting | Phase 2 | Assessment of Antioxidant Therapy on Oxidative Stress Biomarkers in Type 2 Diabetic Patients With Neuropathy | January 9, 2023 | February 20, 2024 |
| NCT05500742 | Active, not recruiting | N/A | Anti-age Dietary Supplements in Healthy Older Adults: the proBNPage Reduction Trial | July 22, 2022 | November 2024 |
| NCT00721877 | Completed | Phase 1 | Resveratrol in Healthy Adult Participants | August 2008 | July 2009 |
| NCT00823381 | Completed | N/A | Effect of Resvida, a Comparison With Calorie Restriction Regimen | January 2009 | December 2010 |
| NCT01038089 | Completed | N/A | Pilot Study Of The Effects Of Resveratrol On Endothelial Function In Subjects With Type 2 Diabetes Mellitus | January 2010 | December 2010 |
| NCT01150955 | Completed | N/A | Potential Beneficial Effects of Resveratrol | October 2010 | November 2011 |
| NCT01321151 | Completed | Phase 1/Phase 2 | Use of Resveratrol to Decrease Acute Secondary Brain Injury Following Sports-Related Concussions in Boxers | March 2011 | November 2011 |
| NCT01324089 | Completed | N/A | Resveratrol With or Without Piperine to Enhance Plasma Levels of Resveratrol | March 2011 | March 2012 |
| NCT01339884 | Completed | Phase 1/Phase 2 | A Study of Resveratrol as Treatment for Friedreich Ataxia | April 2011 | December 2012 |
| NCT01354977 | Completed | Phase 2 | Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans | March 2008 | September 15, 2017 |
| NCT01370889 | Completed | Phase 1 | Resveratrol in Postmenopausal Women With High Body Mass Index | June 2011 | July 2012 |
| NCT01375959 | Completed | N/A | Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance | April 2011 | April 2015 |
| NCT01412645 | Completed | N/A | Long-term Investigation of Resveratrol in Obesity | August 2011 | August 2013 |
| NCT01446276 | Completed | N/A | Long-term Investigation of Resveratrol on Fat Metabolism in Obese Men With Nonalcoholic Fatty Liver Disease | November 2011 | April 2014 |
| NCT01451918 | Completed | Phase 2 | Regulation of Intestinal and Hepatic Lipoprotein Secretion by Resveratrol | October 2011 | September 2013 |
| NCT01464801 | Completed | N/A | Resveratrol in Patients With Non-alcoholic Fatty Liver Disease | September 2011 | June 2015 |
| NCT01476592 | Completed | N/A | A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors | December 2011 | October 11, 2018 |
| NCT01492114 | Completed | Phase 3 | Anti-inflammatory and Antioxidant Effects of Resveratrol on Healthy Adults. | July 2011 | March 2012 |
| NCT00098969 | Completed | Phase 1 | UMCC 2003-064 Resveratrol in Preventing Cancer in Healthy Participants | September 2004 | |
| NCT01564381 | Completed | Phase 1/Phase 2 | Effects of Resveratrol Supplements on Vascular Health in Postmenopausal Women | March 2012 | March 2015 |
| NCT01593605 | Completed | N/A | Resveratrol-Leucine Metabolite Synergy in Pre-diabetes | February 2012 | June 2013 |
| NCT01615445 | Completed | Phase 2 | Resveratrol Supplementation on Exercise in Healthy Sedentary Adults | February 2009 | August 2011 |
| NCT01635114 | Completed | N/A | Effect of resVida on Liver Fat Content | June 2012 | September 2015 |
| NCT01504854 | Completed | Phase 2 | Resveratrol for Alzheimer's Disease | May 2012 | March 2014 |
| NCT00256334 | Completed | Phase 1 | Resveratrol for Patients With Colon Cancer | July 2005 | April 2009 |
| NCT00433576 | Completed | Phase 1 | Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery | December 2006 | March 2009 |
| NCT02475564 | Completed | Phase 4 | Resveratrol for Pain Due to Endometriosis | June 2015 | November 2015 |
| NCT02523274 | Completed | Phase 2 | Resveratrol and Exercise to Treat Functional Limitations in Late Life | June 2016 | July 17, 2019 |
| NCT02565979 | Completed | N/A | Long-term Resveratrol and Metabolism | April 2016 | March 28, 2019 |
| NCT02704494 | Completed | Early Phase 1 | Resveratrol's Effects in Diabetic Nephropathy | March 2016 | February 2017 |
| NCT02909686 | Completed | N/A | Effects of Botanical Microglia Modulators in Gulf War Illness | July 2016 | September 2022 |
| NCT03100019 | Completed | N/A | Supplementation of 500mg Trans-resveratrol Within Hypoxic and Normoxic Conditions, in Healthy Humans. | May 13, 2014 | April 30, 2015 |
| NCT03253913 | Completed | Phase 2 | Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial | March 31, 2018 | October 15, 2022 |
| NCT03352895 | Completed | N/A | The Effects of Resveratrol on the Complications of Patients With Hemodialysis | November 2014 | July 2017 |
| NCT03436992 | Completed | N/A | Estrogen and Diabetes | April 17, 2018 | December 31, 2023 |
| NCT03446625 | Completed | Phase 3 | Resveratrol as a Preventive Treatment of OHSS | March 13, 2018 | June 1, 2019 |
| NCT03448094 | Completed | N/A | The Effects of Resveratrol Supplementation on Cognition, Cerebral Blood Flow, Microbiota and Systemic Inflammation. | February 6, 2018 | July 13, 2019 |
| NCT03525379 | Completed | Phase 2 | Evaluating the Clinical Efficacy of Resveratrol in Improving Metabolic and Skeletal Muscle Function in Patients With Heart Failure | October 26, 2017 | October 8, 2019 |
| NCT03541993 | Completed | N/A | The Cerebral Hemodynamic and Cognitive Effects of Acute Resveratrol Administration in Young, Healthy Adults at Stimulated Altitude. | June 7, 2016 | December 22, 2016 |
| NCT03546075 | Completed | N/A | The Impact of Acute Trans-resveratrol Administration on Whole Body Metabolism During Cognitive Demand. | May 7, 2015 | December 18, 2015 |
| NCT03728777 | Completed | N/A | Resveratrol Supplementation in Patients With Mitochondrial Myopathies and Skeletal Muscle Fatty Acid Oxidation Disorders | April 9, 2018 | October 1, 2019 |
| NCT03743636 | Completed | Phase 3 | Nicotinamide Riboside With and Without Resveratrol to Improve Functioning in Peripheral Artery Disease | October 1, 2018 | May 23, 2023 |
| NCT03819517 | Completed | Early Phase 1 | Improving Cardiovascular Health in Patients With Chronic Obstructive Pulmonary Disease | July 1, 2019 | August 30, 2023 |
| NCT03933163 | Completed | Phase 2 | Micronised Resveratrol as a Treatment for Friedreich Ataxia | May 23, 2019 | March 28, 2024 |
| NCT04314739 | Completed | N/A | The Effects of Resveratrol Supplementation on Inflammation and Cognitive Performance in Healthy Adults | March 19, 2019 | December 19, 2019 |
| NCT04386499 | Completed | N/A | Biological Effects of Treatment With Resveratrol in ART Patients | January 10, 2019 | May 5, 2020 |
| NCT04689412 | Completed | Nasal Resveratrol and Wheezing Episodes in Preschool Children | April 1, 2018 | April 30, 2019 | |
| NCT05172947 | Completed | N/A | Effect of Resveratrol and Pharmacist Intervention on Diabetes Mellitus and Its Neuropathic Complication | December 5, 2021 | December 15, 2022 |
| NCT05653895 | Completed | N/A | Independent and Additive Effects Of Micronutrients With Metformin In Patients With PCOS | December 7, 2022 | February 7, 2024 |
| NCT01640197 | Completed | Phase 1 | Chronic Resveratrol Supplementation in Healthy Humans | February 2011 | June 2012 |
| NCT01668836 | Completed | N/A | Influence of Caloric Restriction and Resveratrol in the Sirtuin System in Women and Men Aged 55 to 65 Years | August 2012 | December 2014 |
| NCT01714102 | Completed | N/A | Resveratrol and the Metabolic Syndrome | October 2012 | July 2018 |
| NCT01747252 | Completed | N/A | Pharmacokinetics of Resveratrol Comprising Products | August 2012 | March 2013 |
| NCT01768507 | Completed | N/A | Reresveratrol Administered to Healthy Male Subjects | March 2011 | March 2011 |
| NCT01782911 | Completed | N/A | Effect of Resveratrol on Metabolic Parameters and Oocyte Quality in PCOS Patients | February 1, 2013 | February 1, 2013 |
| NCT01881347 | Completed | N/A | Effects of Resveratrol on Endothelial Function in Type 2 Diabetes Mellitus | January 1, 2013 | July 2016 |
| NCT02030977 | Completed | Phase 2/Phase 3 | The Effects of Resveratrol Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis | June 2012 | March 2013 |
| NCT02062190 | Completed | Phase 2 | Resveratrol, Cardiovascular Risk Markers And Cognitive Performance In Patients With Schizophrenia | March 2014 | May 2015 |
| NCT02114892 | Completed | Phase 2 | Effect of Resveratrol Administration on Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion | April 2012 | September 2013 |
| NCT02129595 | Completed | N/A | Resveratrol and First-degree Relatives of Type 2 Diabetic Patients | April 2014 | July 31, 2017 |
| NCT02216552 | Completed | Phase 2/Phase 3 | Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents | August 2015 | March 20, 2017 |
| NCT02219906 | Completed | N/A | Resveratrol in Metabolic Syndrome: Effect on Platelet Hyper-reactivity and HDL Lipid Peroxidation | May 2014 | April 7, 2019 |
| NCT02244879 | Completed | Phase 3 | Effects of Resveratrol on Inflammation in Type 2 Diabetic Patients | October 2013 | February 2016 |
| NCT02245932 | Completed | N/A | Resveratrol In Chronic Obstructive Pulmonary Disease (COPD) Patients (CARMENS-trial) | January 2015 | November 2017 |
| NCT02246660 | Completed | N/A | RESveratrol To Improve Outcomes in oldeR pEople With PAD (the RESTORE Trial) | January 2015 | September 2016 |
| NCT02247596 | Completed | Phase 2 | Effects of High-Dose Resveratrol in Non-Diabetic Obese Males | July 2009 | October 2012 |
| NCT02256540 | Completed | N/A | The Effects of Resveratrol and Acute Exercise on Endothelial Function in Postmenopausal Women | August 2014 | March 25, 2016 |
| NCT02314208 | Completed | Phase 2 | Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5 | January 2015 | January 1, 2018 |
| NCT02336633 | Completed | N/A | Resveratrol and Huntington Disease | July 2015 | January 2020 |
| NCT02409537 | Completed | Phase 2 | Effects of Dietary Antioxidants to Prevent Cardiovascular Disease | March 2013 | March 2015 |
| NCT02433925 | Completed | Phase 3 | Resveratrol's Effects on Inflammation and Oxidative Stress in Chronic Kidney Disease | January 2013 | December 2014 |
| NCT06235294 | Not yet recruiting | N/A | Effects of Resveratrol Supplementation on Oocyte Quality | September 2024 | December 2025 |
| NCT05808387 | Recruiting | N/A | The Effects of Resveratrol on Sirtuins and Apoptosis Biomarkers | March 6, 2023 | June 5, 2026 |
| NCT06250283 | Recruiting | N/A | Resveratrol for the Prevention of Bone Loss in Postmenopausal Women | February 2, 2024 | December 31, 2024 |
| NCT04449198 | Recruiting | Early Phase 1 | Type 1 Diabetes, Endothelin, and Skeletal Muscle Mitochondrial Dysfunction: The Role of Sirtuin-1 | October 14, 2020 | July 1, 2025 |
| NCT05410093 | Recruiting | N/A | Clinical Efficacy Analysis of Resveratrol in the Treatment of Primary Ovarian Insufficiency | February 1, 2022 | July 31, 2024 |
| NCT04166396 | Recruiting | Early Phase 1 | Non-pulmonary Contributors of Exercise Intolerance in Patients With Cystic Fibrosis | February 17, 2020 | January 2025 |
| NCT05377242 | Recruiting | N/A | Curcumin, Resveratrol, and Stinging Nettle as Treatments for GWI | May 31, 2023 | June 30, 2026 |
| NCT04400890 | Terminated | Phase 2 | Randomized Proof-of-Concept Trial to Evaluate the Safety and Explore the Effectiveness of Resveratrol, a Plant Polyphenol, for COVID-19 | September 13, 2020 | March 1, 2021 |
| NCT03866200 | Terminated | Phase 2 | Resveratrol Trial for Relief of Pain in Pseudoachondroplasia | June 29, 2019 | October 28, 2020 |
| NCT01842399 | Terminated | Phase 1/Phase 2 | Resveratrol and Cardiovascular Health in the Elderly | July 14, 2015 | December 21, 2022 |
| NCT04542993 | Terminated | Phase 2 | Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy | September 8, 2020 | February 5, 2021 |
| NCT02549924 | Terminated | Phase 2 | Effect of Administration of Resveratrol on Glycemic Variability in Individuals With Type 2 Diabetes Mellitus | September 2016 | February 1, 2018 |
| NCT01997762 | Unknown status | Phase 4 | Can Resveratrol Improve Insulin Sensitivity and Preserve Beta Cell Function Following Gestational Diabetes? | May 2014 | December 2016 |
| NCT04799743 | Unknown status | N/A | The Anti-fibrotic Therapeutic Effects of Resveratrol for Discharged COVID-19 Patients | April 1, 2021 | May 2022 |
| NCT01244360 | Unknown status | N/A | The Effects of Resveratrol Supplementation on Measurements of Health and Human Performance | November 2010 | June 2011 |
| NCT03665740 | Unknown status | Phase 2 | Multimodal Investigation of the Neuroprotective Effects of Resveratrol (MINER) | August 1, 2018 | August 31, 2022 |
| NCT01826279 | Unknown status | N/A | Short-term Investigation of Resveratrol on Fat Metabolism in Morbidly Obese Women Undergoing Gastric Bypass Surgery | May 2013 | August 2014 |
| NCT01914081 | Unknown status | Phase 3 | Resveratrol: A Potential Anti- Remodeling Agent in Heart Failure, From Bench to Bedside | October 9, 2018 | November 2020 |
| NCT01638780 | Unknown status | N/A | Resveratrol and Type 2 Diabetes | May 2012 | December 2014 |
| NCT02947932 | Unknown status | Phase 4 | Oral Resveratrol to Prevent Post-ERCP Pancreatitis | December 2016 | September 2018 |
| NCT00996229 | Unknown status | Phase 3 | Effects of Dietary Interventions on the Aging Brain | November 2009 | February 2014 |
| NCT00654667 | Withdrawn | Phase 2 | Mechanisms of Metabolic Regulation of Resveratrol on Humans With Metabolic Syndrome | May 2007 | August 2008 |
| NCT02261844 | Withdrawn | Phase 1/Phase 2 | Resveratrol and Human Hepatocyte Function in Cancer | December 2015 | June 2016 |